Targeting mGlu7 could lead to new anxiety and PTSD treatments
Addex Therapeutics has published new research showing that targeting the…
Addex Therapeutics has published new research showing that targeting the mGlu7 receptor with a negative allosteric modulator can disrupt fear memory reconsolidation, offering a potential new approach to treating anxiety and PTSD.




